Undergraduate Medicine Student, School of Medical Sciences, Santa Casa de São Paulo, São Paulo (SP), Brazil.
MD, PhD. Associate Professor, Department of Internal Medicine, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo (SP), Brazil.
Sao Paulo Med J. 2022 Sep 12;141(3):e2021914. doi: 10.1590/1516-3180.2021.0914.R2.13062022. eCollection 2022.
There is discrepant information across countries regarding the natural history of patients admitted to hospitals with coronavirus disease (COVID-19), in addition to a lack of data on the scenario in Brazil.
To determine the mortality predictors in COVID-19 patients admitted to a tertiary hospital in São Paulo, Brazil.
A retrospective analysis of medical records of COVID-19 patients admitted to the Hospital Central da Irmandade da Santa Casa de Misericórdia of São Paulo.
Overall, 316 patients with laboratory-confirmed COVID-19 between March 1, 2020, and July 31, 2020, were included. The analysis included the baseline characteristics, clinical progression, and outcomes.
The mortality rate of the sample was 51.27%. Age ≥ 60 years was determined as a risk factor after multivariate logistic regression analysis. Patients with an oxygen (O2) saturation ≤ 94% upon admission accounted for 87% of the deaths (P < 0.001). Vasoactive drugs were used in 92% (P < 0.001) of patients who progressed to death, and mechanical ventilation was employed in 88% (P < 0.001) of such patients. However, patients who received corticosteroids concomitantly with mechanical ventilation had a better prognosis than those who did not. The progressive degree of pulmonary involvement observed on chest computed tomography was correlated with a worse prognosis. The presence of thrombocytopenia has been considered as a risk factor for mortality.
The main predictors of in-hospital mortality after logistic regression analysis were age, O2 saturation ≤ 94% upon admission, use of vasoactive drugs, and presence of thrombocytopenia.
除了巴西的情况缺乏数据外,各国关于因冠状病毒病(COVID-19)住院患者的自然史的信息也存在差异。
确定在巴西圣保罗一家三级医院住院的 COVID-19 患者的死亡预测因素。
对 2020 年 3 月 1 日至 7 月 31 日期间在圣保罗 Irmandade da Santa Casa de Misericórdia 中央医院住院的 COVID-19 患者的病历进行回顾性分析。
共有 316 例经实验室确诊的 COVID-19 患者被纳入研究。分析包括基线特征、临床进展和结局。
样本的死亡率为 51.27%。多变量逻辑回归分析确定年龄≥60 岁为危险因素。入院时血氧饱和度≤94%的患者占死亡人数的 87%(P<0.001)。进展至死亡的患者中有 92%(P<0.001)使用了血管活性药物,88%(P<0.001)使用了机械通气。但是,同时接受机械通气和皮质类固醇治疗的患者预后好于未接受治疗的患者。胸部计算机断层扫描显示的肺部受累进展程度与预后较差相关。血小板减少症被认为是死亡的危险因素。
经逻辑回归分析,住院死亡率的主要预测因素是年龄、入院时血氧饱和度≤94%、使用血管活性药物和存在血小板减少症。